Therefore, despite the increased hydrodynamic size of scFv, it can be expected that in vivo distribution will be enhanced compared to unmodified scFvs or monoclonal antibody, due to increased blood circulation time and albumin’s own selectivity toward tumor. This evidence concerns the gene ALB and neoplasm.